OSCR Stock: Price, Earnings History and SEC Filings
Oscar Health, Inc. (OSCR) last traded at $30.37, down 1.36% on the latest session and down 1.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.10 against an analyst estimate of $0.43, a beat of 155.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
OSCR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $1.10 | $0.43 | +155.81% |
| Mar 2026 | May 6, 2026 | $2.07 | $1.21 | +71.07% |
| Dec 2025 | Feb 10, 2026 | $-1.24 | $-0.84 | -47.62% |
| Sep 2025 | Nov 6, 2025 | $-0.53 | $-0.55 | +3.64% |
OSCR beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How OSCR reacts to earnings
Across its last 8 earnings releases, OSCR moved 9.0% on average the next session, in either direction. It rose after 6 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | Before open | -11.86% |
| 2026-05-06 | Before open | +10.59% |
| 2026-02-10 | Before open | +1.74% |
| 2025-11-06 | Before open | -2.76% |
| 2025-08-06 | Before open | +3.76% |
| 2025-07-22 | Before open | +7.93% |
| 2025-05-07 | Before open | +30.22% |
| 2025-02-04 | After close | +3.08% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
OSCR financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $11.7B | -$443M | – | -3.8% | $-1.69 |
| 2024 | $9.2B | $25M | – | 0.3% | $0.10 |
| 2023 | $5.9B | -$271M | – | -4.6% | $-1.22 |
| 2022 | $4.0B | -$606M | – | -15.3% | $-2.85 |
| 2021 | $1.8B | -$573M | – | -31.1% | $-3.20 |
| 2020 | $463M | -$407M | – | -87.9% | $-14.16 |
| 2019 | $488M | -$261M | – | -53.5% | $-9.06 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for OSCR
- 8-K · Sep 16, 2026Regulation FD disclosure
- 10-Q · Aug 7, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 9, 2026Shareholder vote
- 8-K · Jun 8, 2026Regulation FD disclosure
- 8-K · Jun 2, 2026Officer or director change
- 10-Q · May 7, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 22, 2026
- 8-K · Apr 21, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
OSCR insiders filed 13 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
OSCR news
- Oscar Health Inc - Class ANov 1, 2026 · 247wallst.com
- Oscar Health, Inc. (OSCR) is Attracting Investor Attention: Here is What You Should KnowOct 30, 2026 · finance.yahoo.com
- Best Growth Stocks to Buy for October 30thOct 30, 2026 · finance.yahoo.com
- Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to KnowOct 29, 2026 · finance.yahoo.com
- Lucie and CHOICE Broaden the Growth Runway for Oscar HealthOct 29, 2026 · finance.yahoo.com
- Oscar Health (OSCR) Stock May Trade Below Fair Value As New Plans Roll OutOct 28, 2026 · finance.yahoo.com
- Best Growth Stocks to Buy for October 28thOct 28, 2026 · finance.yahoo.com
- Best Growth Stocks to Buy for October 26thOct 26, 2026 · finance.yahoo.com
About Oscar Health, Inc.
Oscar Health, Inc. (OSCR) is a US-listed public company on NYSE. The SEC classifies its business as Hospital & Medical Service Plans. It is incorporated in DE. Its fiscal year ends in December.